Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Spannagl

Showing results (11-20 of 130) with videos related to

Pageof 13
Sort By:
Current Drug Targets|November 1, 2006
Thrombin inhibitors and anti-factor Xa agents in the treatment of arterial occlusionV Klauss, M Spannagl
Hamostaseologie|December 5, 2013
Direct oral anticoagulants and antiplatelet agents. Clinical relevance and options for laboratory testingD Sibbing, M Spannagl
Der Anaesthesist|April 24, 2001
[New platelet inhibitors]M Spannagl, L Frey
Der Internist|July 27, 1999
[Hemostaseology--rational diagnosis]M Spannagl, W Schramm
Der Internist|April 10, 2014
[Coagulation disorders in the intensive care station]C Hart, M Spannagl
Der Internist|July 1, 1994
[Rational diagnosis in blood coagulation disorders]M Spannagl, W Schramm
Der Internist|February 1, 1992
[Pregnancy in thrombophilic diathesis]M Spannagl, W Schramm
Der Anaesthesist|May 25, 2006
[Fresh plasma and concentrates of clotting factors for therapy of perioperative coagulopathy: what is known?]B Heindl, M Spannagl
Deutsche Medizinische Wochenschrift (1946)|March 20, 1998
[Activated protein C resistance in factor V disease: how high is the risk of thrombosis?]M Spannagl, W Schramm
Der Internist|March 31, 1999
[Vitamin K agonists in cerebral microembolism?]M Spannagl, W Schramm
Pageof 13

Showing results (11-20 of 130) with videos related to

Sort By:
Pageof 13
Current Drug Targets|November 1, 2006
Thrombin inhibitors and anti-factor Xa agents in the treatment of arterial occlusionV Klauss, M Spannagl
Hamostaseologie|December 5, 2013
Direct oral anticoagulants and antiplatelet agents. Clinical relevance and options for laboratory testingD Sibbing, M Spannagl
Der Anaesthesist|April 24, 2001
[New platelet inhibitors]M Spannagl, L Frey
Der Internist|July 27, 1999
[Hemostaseology--rational diagnosis]M Spannagl, W Schramm
Der Internist|April 10, 2014
[Coagulation disorders in the intensive care station]C Hart, M Spannagl
Der Internist|July 1, 1994
[Rational diagnosis in blood coagulation disorders]M Spannagl, W Schramm
Der Internist|February 1, 1992
[Pregnancy in thrombophilic diathesis]M Spannagl, W Schramm
Der Anaesthesist|May 25, 2006
[Fresh plasma and concentrates of clotting factors for therapy of perioperative coagulopathy: what is known?]B Heindl, M Spannagl
Deutsche Medizinische Wochenschrift (1946)|March 20, 1998
[Activated protein C resistance in factor V disease: how high is the risk of thrombosis?]M Spannagl, W Schramm
Der Internist|March 31, 1999
[Vitamin K agonists in cerebral microembolism?]M Spannagl, W Schramm
Pageof 13